Navigation Links
DiaTrends

ProductsDiaTrends
Company Overlook Software, Inc.
Item DiaTrends
Features 
  • DiaTrends allows the physician or other diabetes care provider to easily track adherence to key processes and outcomes of diabetes care in the population of people with diabetes for whom he or she is providing care.
  • Its familiar Windows graphical user interface (and underlying relational database format) allows quick, easy, intuitive entry of a wide variety of patient information pertinent to diabetes care.
  • Data can be easily updated at the time of each clinical encounter and reviewed in a consistent, comprehensive and simple format.
  • Prompts are provided to help remind the user of processes of care which may be due.
  • DiaTrends is an efficient and comprehensive aid to timely, preventive care.
  • It is designed to complement, not replace, the medical record.
Description DiaTrends - innovative diabetes management software - was designed by practicing clinical endocrinologists. This quality improvement tool helps diabetes care providers achieve optimal diabetes outcomes. DiaTrends bridges medicine with technology by providing a state-of-the-art, robust, user-friendly diabetes management information technology product. This diabetes software is designed to complement, not replace, the medical record. By tracking individual patients and using aggregate data to develop systematic approaches to healthcare improvement, DiaTrends helps achieve diabetes outcomes that adhere to published clinical guidelines. Diabetes management with DiaTrends improves workflow productivity and is an efficient and comprehensive aid to timely, focused preventive healthcare. DiaTrends has demonstrated improvements in all parameters of quality diabetes outcomes.
Info Overlook Software, Inc.
Customer Service: (336) 274-0066
Web site: http://www.overlooksoftware.com

Related medicine products :

1. Iso-Insulin EIA Diabetes and Obesity Markers 008-10-1128-01
2. Insulin Ultrasensitive EIA Diabetes and Obesity Markers 008-10-1132-01
3. Ultrasensitive C-Peptide EIA Diabetes and Obesity Markers 008-10-1141-01
4. Insulin EIA Diabetes and Obesity Markers 008-10-1113-01
5. C-Peptide EIA Diabetes and Obesity Markers 008-10-1136-01
6. Insulin Jumbo EIA Diabetes and Obesity Markers 008-10-1113-99
7. Ascensia Win Glucofacts Diabetes Management Software
8. Duet Diabetes Control System
9. Precision Xtra Advanced Diabetes Tester
10. Lyphochek Diabetes Control
11. Practice Partner Patient Records
TDX Tape - sealing sheets for polypropylene plates only, 100/PK...
For use with 96-well plates, catalog # 410150...
The Heat Sealing Foil and Heat...
... area that will help protect your PCR ... the work area prior to use, reducing ... amplified. Containment features reduce the chance of ... windows for a clear view, an acid-resistant ...
Medicine Products:
(Date:6/28/2017)... ... June 28, 2017 , ... ... financial consultations to communities in northern Virginia and DC, is announcing a cooperative ... for patients with Alzheimer’s and other disorders that lead to memory impairment. , ...
(Date:6/27/2017)... , ... June 27, 2017 , ... DrugDev ... is whether they can trust the sponsor to pay them correctly and on time. ... and CROs establish payment strategies that encourage sites to work on their studies. , ...
(Date:6/27/2017)... ... June 27, 2017 , ... Building on the ... Louisiana became the sixth state to pass legislation which ensures that children can ... signature, Louisiana joins the states of Alabama, Arizona, Florida, Utah and Washington who ...
(Date:6/27/2017)... ... 2017 , ... The Kelahan Agency, a privately owned firm ... southern New Hampshire, is teaming up with the New Horizons for New Hampshire ... the region. , New Horizons for New Hampshire provides a wealth of services ...
(Date:6/27/2017)... Monroe, CT (PRWEB) , ... June 27, 2017 , ... ... announce the recent renovation of his practice, Advanced Periodontics and Dental Implant Center of ... and increased the administrative and waiting areas. The renovations are intended to improve patient ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
(Date:6/5/2017)... , June 5, 2017 The ... brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded ... Cincinnati Enquirer . Results are based on an ... in organizational health and workplace improvement. The survey measures several ... ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
Breaking Medicine Technology: